Neoadjuvant FOLFIRINOX 🤜🤛upfront surgery for resectable pancreatic cancer NORPACT-1 out 🔥 now @LancetGastroHep 📈 Median OS 25 vs. 38 months and resection rate did not differ 💉 60% neoadjuvant group had severe adverse event 🚨 🫵Comments?🧐 👉 https://t.co/zhikhG8XQN

Pancreatic exocrine insufficiency 💊 after non pancreas upper GI surgery - meta analysis Incidence 3️⃣6️⃣ % 😳 Most patients (80%) responding positively to pancreatic enzyme replacement 🇮🇹 Of note there is currently a shortage of enzymes in Italy 😰 https://t.co/5Io5xelwpD

Great to see this out there, 💩 PEI after non pancreatic UGI surgery. ⬆️ Especially BPD/DS or gastrectomy 💊 Improvements with PERT 🧐 Should we be treating @_lewis_hall @UHB_HPB @MarkarSheraz @TomWiggins23 @jameshallesmith https://t.co/byG6QbmCXF

Investigating less recognised causes of PEI 🥳 Excellent output from an iBSc with @UHB_HPB 👏 @_lewis_hall. More to come.

@DrSfpb presenting her research on novel diagnostic test in PEI. Very exciting data after lots of hard work. Absolute pleasure to have supervised her PhD. Thank you

@Adam_Frampton1 @Drsampathak @sanjay_HPB

@GSTTnhs @ChelwestFT @PHU_NHS Our next nominee for the #SilverScalpel 2024 award is a Consultant Colorectal and Paediatric Surgeon at Birmingham Heartlands Hospital - we present to you Mr Mark Dilworth! 👏 #NoTrainingToday #NoSurgeonsTomorrow has never been more true 🎯

Can we get a drumroll please?! 🥁🥁🥁 It is indeed that time of the year again! ASiT is proud to present you our Swann-Morton #SilverScalpel 2024 nominees! 👏🏻👏🏽👏🏿

Early postoperative risk stratification in patients with pancreatic fistula after pancreaticoduodenectomy https://t.co/7ZFElCTksS @DrSfpb @alemarche055 @Giampaolo_Perri @UHB_HPB @Gio_Marchegiani @liveRPancSurg @SWexner @juliomayol @SyedAAhmad5 @shimulshah73 #SoMe4Surgery

Looking forward to seeing these in print, and delighted with the dietetic content with @SineadNDuggan

Great work from @_lewis_hall, Picking up prizes @Augishealth Exciting trial incoming *PHAGOS* 🔪 metabolomic surgery and oesophagogastric resection 🤔 ? true incidence of PEI 💊 could PERT be beneficial @MarkarSheraz @TomWiggins23 @UHB_HPB @jameshallesmith

Presentation Bingo

Our PERFECT trial finally out in @TheLancet ! Pragmatic Nordic 🇫🇮🇳🇴 multicenter RCT comparing appendectomy within 24h versus 8h. 1803 patients! No difference in rate of perforated appendicitis (9% vs 8%). 👉 Allows to postpone appendectomy to daytime. https://t.co/AK77BsrTtG

Funny week 🌟 data showing better outcomes with female surgeons 😱 president of the RCS implies that women get easier cases 🧐 data showing shocking sexual assault stats in surgery 🤦🏻‍♀️ @thetimes gives validity to old bloke saying it's all banter and put up @WomenSurgeonsUK

#TraineeTuesdays Retrospective analysis of the HART trial data found that incisional hernia rates at 1 year were greater when abdominal closure was performed by trainees. #SoMe4Surgery🧐 @TorkiJ

NOW OF: In the final 10-yr survival analysis of the OVHIPEC-1 ph 3 RCT of cytoreductive surgery w/o vs w/ HIPEC in pts with adv ovarian cancer, median PFS was 10·7 months (95% CI 9·6–12·0) vs 14·3 months (12·0–18·5); HR 0·63 [95% CI 0·48–0·83], p=0·0008). https://t.co/QWlQVN08GP

Predict Pancreatic Fistula 🐳 using only preoperative data and Machine Learning 🤖 🇺🇸 ACS-NQIP @AmCollSurgeons 9k whipples 4 models identified 🔝 predictors as BMI, 🤏 small duct, NO chemo / adenocarcinoma 👏 Great tool, when would you apply it ?! 🧐 https://t.co/wN2ETyOIR8

@jameshallesmith @_lewis_hall

https://t.co/uvq7Bwooii

https://t.co/9YKTCb4qXm